ANGIOTECH PHARMACEUTICALS INC

Yahoo! Finance: ANP.TO NewsLatest Financial News for ANGIOTECH PHARM

URL

XML feed
http://finance.yahoo.com/q/h?s=anp.to

Last update

5 min 4 sec ago

July 30, 2010

14:26
UPDATE - Angiotech loss widens as royalties slow (at Reuters)
10:33
UPDATE - Angiotech loss widens as royalties slow (at Reuters)
06:00
Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 (CNW Group)

July 28, 2010

15:37
Angiotech Pharmaceuticals and partner Athersys announce positive results from phase I study of MultiStem(R) in heart attack patients (CNW Group)
02:15
Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2010 (PR Newswire)
Angiotech Pharmaceuticals, Inc. today announced its financial results for the first quarter ended March 31, 2010.

July 27, 2010

11:17
Angiotech announces exclusive distribution agreement with B. Braun for Angiotech's proprietary Quill(TM) SRS product line (CNW Group)

July 23, 2010

22:23
Angiotech's licensee, Cook Medical, files PMA submission for FDA approval of Zilver(R) PTX(R) Drug-Eluting Stent platform (CNW Group)
17:56
Canada corporate earnings schedule - July 12-30 (at Reuters)
14:52
Canada corporate earnings schedule-July 26-Aug 13 (at Reuters)
01:53
Angiotech Pharmaceuticals announces acceptance of 2010 medical design excellence award for Quill(TM) SRS (CNW Group)
01:53
Boston Scientific launches new Taxus stent in EU (AP)
Boston Scientific Corp. said Thursday that it launched its Taxus Element drug-coated coronary stent in Europe, and that physicians there have started using the device in surgical procedures.
01:53
Angiotech Pharmaceuticals announces European launch and first implants of Boston Scientific Corporation's platinum chromium TAXUS(R) Element(TM) Stent System (CNW Group)
00:45
Angiotech Pharmaceuticals Announces Conference Call and Webcast (CNW Group)

July 22, 2010

17:29
Angiotech Pharmaceuticals announces notice of failure to satisfy a continued listing rule with The Nasdaq Stock Market. (CNW Group)
03:38
Angiotech Pharmaceuticals announces European approval of Boston Scientific Corporation's platinum chromium TAXUS(R) Element(TM) Stent System (CNW Group)

July 20, 2010

20:50
Angiotech's licensee, Cook Medical, announces single-arm study reveals 86.2 percent SFA vessel patency for Zilver(R) PTX(TM) (CNW Group)

July 19, 2010

19:17
Novavax names former FDA officer as medical chief (AP)
Drug developer Novavax Inc. said Monday it has named former FDA officer Mark Thornton as its new head of development and chief medical officer.
19:17
Novavax names FDA insider as chief medical officer (AP)
Drug developer Novavax Inc. said Monday it has named former FDA officer Mark Thornton as its new head of development and chief medical officer.